US FDA grants the coveted Breakthrough Designation for early-stage prostate cancer detection blood test developed in India by Datar Cancer Genetics
Feb 15, 2022
Mumbai (Maharashtra) [India], February 15 (ANI/PR Newswire): Datar Cancer Genetics today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Designation'...